Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% in Subjects With Open-Angle Glaucoma or Ocular Hypertension: Integrated Analysis of Two Phase 3 Studies

Publications // Jan 12 2018

Weinreb RN, Liebmann JM, Martin KR, Kaufman PL, Vittitow JL: Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: Integrated Analysis of Two Phase 3 Studies. J Glaucoma 27(1):7-15, 2018 doi: 10.1097/IJG.0000000000000831